Corruption and Averting Aids Deaths

40 Pages Posted: 27 Jun 2015

See all articles by Willa Friedman

Willa Friedman

University of Houston - Department of Economics

Date Written: February 25, 2015

Abstract

This paper looks at the impact of corruption on the effectiveness of antiretroviral drugs in preventing AIDS deaths and the potential channels that generate this relationship. This is based on a unique panel dataset of countries in sub-Saharan Africa, which combines information on all imported antiretroviral drugs (ARVs) from the World Health Organization's Global Price Reporting Mechanism with measures of corruption and estimates of the HIV prevalence and the number of AIDS deaths in each year and in each country. Countries with higher levels of corruption experience a significantly smaller drop in AIDS deaths as a result of the same quantity of ARVs imported. This is robust to different measures of corruption and to a measure of overall death rates as well as HIV-specific death rates as the outcome. A case-study analysis of the Kenyan experience illustrates one potential mechanism for the observed effect, demonstrating that disproportionately more clinics begin distributing ARVs in areas that are predominantly represented by the new leader's ethnic group.

Keywords: HIV/AIDS, antiretroviral drugs, corruption

JEL Classification: I15, D73

Suggested Citation

Friedman, Willa, Corruption and Averting Aids Deaths (February 25, 2015). Center for Global Development Working Paper No. 395. Available at SSRN: https://ssrn.com/abstract=2623085 or http://dx.doi.org/10.2139/ssrn.2623085

Willa Friedman (Contact Author)

University of Houston - Department of Economics ( email )

Houston, TX 77204-5882
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
13
Abstract Views
174
PlumX